Skip to main content
Clinical Trials/NCT00978588
NCT00978588CompletedNot Applicable

Comparison of 6% Hydroxyethyl Starch 130/0.4 With 5% Albumin as Priming Solution for Cardiopulmonary Bypass

Yonsei University0 sites36 target enrollmentStarted: February 2008Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
36
Primary Endpoint
the pure effect of priming solutions

Study Overview

Brief Summary

Comparison of 6% hydroxyethyl starch 130/0.4 with 5% albumin as priming solution for cardiopulmonary bypass

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Mitral valvular heart disease

Exclusion Criteria

  • Status of Infection
  • Re-operation
  • Liver failure
  • Renal disease
  • Administration of steroid

Arms & Interventions

HES 130/0.4

Experimental

Intervention: 6% hydroxyethyl starch 130/0.4 and 5% albumin (Drug)

5% albumin

Active Comparator

Intervention: 6% hydroxyethyl starch 130/0.4 and 5% albumin (Drug)

Outcomes

Primary Outcomes

the pure effect of priming solutions

Time Frame: after CPB

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Similar Trials